Neumora Therapeutics, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
NMRA on Nasdaq
Location
490 Arsenal Way, Suite 200, Watertown, MA

Insiders trading volume in the past year

Neumora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amgen Inc 10%+ Owner $424M Sep 19, 2023
Kristina Burow Director, 10%+ Owner $383M Jun 13, 2024
ARCH Venture Partners X, LLC 10%+ Owner $383M Dec 8, 2023
ARCH Venture Partners XII, LLC 10%+ Owner $383M Dec 8, 2023
Paul L. Berns Director $93.7M Feb 14, 2024
Fmr Llc Other* $67.4M Sep 19, 2023
Henry O. Gosebruch President & CEO, Director $7.07M Feb 14, 2024
Robert A. Lenz Head of R&D $4.75M -$1.08M -18.5% Oct 9, 2024
Carol Y. Suh Chief Operating Officer $4.49M Feb 14, 2024
Joshua Pinto Chief Financial Officer $2.55M -$1.16M -31.3% Aug 27, 2024
Daljit Singh Aurora Chief Strategy Officer $2.42M Sep 12, 2024
Matthew K. Fust Director $342K -$371K -52% Oct 17, 2024
Michael Lee Milligan Title: SVP Finance & Principal Accounting Officer $293K Feb 14, 2024
Maykin Ho Director $241K Jun 13, 2024
David Piacquad Director $241K Jun 13, 2024
Alaa Halawa Director $241K Jun 13, 2024
Jason Duncan Chief Legal Officer Dec 11, 2023

Recent Insider Transactions by Companies or Individuals for Neumora Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.